लोड हो रहा है…
Evaluating the impact of glucokinase activation on risk of cardiovascular disease: a Mendelian randomisation analysis
BACKGROUND: Glucokinase activators (GKAs) are an emerging class of glucose lowering drugs that activate the glucose-sensing enzyme glucokinase (GK). Pending formal cardiovascular outcome trials, we applied two-sample Mendelian randomisation (MR) to investigate the impact of GK activation on risk of...
मुख्य लेखकों: | , , , , , , , , |
---|---|
स्वरूप: | Online लेख मूलपाठ |
भाषा: | English |
प्रकाशित: |
BioMed Central
2022
|
विषय: | |
ऑनलाइन पहुंच: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503210/ https://www.ncbi.nlm.nih.gov/pubmed/36151532 http://dx.doi.org/10.1186/s12933-022-01613-6 |